uniQure

Why Novo Nordisk should buy Uniqure
Why Novo Nordisk should buy Uniqure
EP Vantage
Novo Nordisk
gene editing
hemophilia
uniQure
Bluebird Bio
Flag link:
UniQure stays a step ahead in hemophilia B
UniQure stays a step ahead in hemophilia B
Biopharma Dive
uniQure
gene therapy
hemophilia B
clinical trials
AMT-061
Flag link:
Why biotech companies are often at the whim of things they cannot control, in one chart
Why biotech companies are often at the whim of things they cannot control, in one chart
Stat
uniQure
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Flag link:
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Endpoints
uniQure
M&A
gene therapy
Flag link:
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
Biopharma Dive
uniQure
gene therapy
Huntington's disease
clinical trials
AMT-130
Flag link:
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
Investors Business Daily
uniQure
M&A
hemophilia B
AMT-061
Pfizer
Spark Therapeutics
Flag link:
Uniqure turns the screw on Spark and Pfizer
Uniqure turns the screw on Spark and Pfizer
EP Vantage
uniQure
Spark Therapeutics
Pfizer
AMT-061
hemophilia B
Flag link:
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
UniQure’s hemophilia B gene therapy achieves 31% FIX activity
Fierce Biotech
uniQure
hemophilia B
gene therapy
FIX-Padula
Flag link:
Who will pay for CRISPR?
Who will pay for CRISPR?
Stat
CRISPR
gene therapy
uniQure
Editas
Spark Therapeutics
Flag link:
Biotech firm pulls pioneering gene therapy due to no demand
Biotech firm pulls pioneering gene therapy due to no demand
Yahoo/Reuters
uniQure
gene therapy
Glybera
Flag link:
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Shire cans Baxalta hemophilia B gene therapy, thinning field for uniQure, Spark
Fierce Biotech
Shire
Baxalta
hemophilia B
gene therapy
BAX 335
Spark Therapeutics
uniQure
Flag link:
Positive hemophilia B gene-therapy results boost UniQure stock
Positive hemophilia B gene-therapy results boost UniQure stock
BioPharma Dive
uniQure
hemophilia B
Flag link:
UniQure's Gene Therapy Boosts Clotting in Two Hemophiliacs
UniQure's Gene Therapy Boosts Clotting in Two Hemophiliacs
Bloomberg
uniQure
gene therapy
hemophilia B
AMT-060
Flag link:
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy
Yahoo
uniQure
gene therapy
Flag link:
FDA demands another study for uniQure's ultra-pricey gene therapy
FDA demands another study for uniQure's ultra-pricey gene therapy
BioPharma Dive
FDA
uniQure
gene therapy
lipoprotein lipase deficiency
Glybera
Flag link:
The 5 Most Expensive Drugs in the World in 2015
The 5 Most Expensive Drugs in the World in 2015
Motley Fool
drug pricing
Glybera
Soliris
Naglazyme
Vimizim
Elaprase
Shire
Biomarin
Alexion
uniQure
Flag link:
UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal
UniQure plans $100M follow-on offering in afterglow of big-ticket Bristol deal
Fierce Biotech
uniQure
Bristol-Myers Squibb
M&A
Flag link:
Bristol-Myers buys into Dutch gene therapy company uniQure
Bristol-Myers buys into Dutch gene therapy company uniQure
Yahoo/Reuters
Bristol-Myers Squibb
uniQure
gene therapy
Flag link:
UniQure bets on a gene therapy for heart failure
UniQure bets on a gene therapy for heart failure
Fierce Biotech
uniQure
congestive heart failure
AAV-S100A1
Flag link:

Pages